Sanford Burnham Prebys receives landmark gift from T. Denny Sanford to recruit the top minds in biomedical research

The Institute plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology

Incurable liver disease may prove curable

Research from Sanford Burnham Prebys has found a drug that can spur liver regeneration in Alagille syndrome

Childhood cancer trailblazer Lukas Chavez joins Sanford Burnham Prebys

His research tackles the world’s cruelest cancers

Liver cancer study encourages caution with certain gene therapies

A newly discovered link between protein misfolding and liver cancer could help improve gene therapy for hemophilia

Sanford Burnham Prebys announces start of Phase 2 clinical trial of DS-1211 in individuals with pseudoxanthoma elasticum

Daiichi Sankyo initiates Phase 2 trial for drug developed with Sanford Burnham Prebys